The Cardiorenal Risk Reduction in Adults Pocket Guide is now here! Pocket Guides are our most popular tools due to their practicality and we are excited to include this excellent addition to the current suite.
The Cardiorenal Risk Reduction in Adults Pocket Guide is a quick reference tool full of simple algorithms to assist cardiovascular physicians on how to approach the use and integration of GLP-1 Receptor Agonists and SGLT2 Inhibitors into practice. Summary tables, including the key recommendations of the CCS Cardiorenal Guidelines and the benefits of these drug classes on cardiorenal outcomes are also included.
Interested in learning more about the CCS Cardiorenal Guidelines? Click here to view the CCS Cardiorenal Protection webinars on demand, and click here to view the Guidelines summary for healthcare providers infographic.
Other NewsSee All
New: The CCS/CHFS 2023 Focused Clinical Practice Update of Patients With Differing Heart Failure Phenotypes
August 8, 2023
In this clinical practice update (CPU) we aim to provide responses to fundamental questions that...Guidelines Heart failure Phenotypes
June 14, 2023
We are excited to officially launch a new resource called Guidelines & KT Tools, housed on the...Guidelines iCCS KT Tools
Two classes of glucose-lowering drugs reduce risk of heart failure, kidney complications and death – even in patients without type 2 diabetes
September 30, 2022
New Cardiorenal Protection Guideline urges use of GLP-1RA and SGLT2i drugs to save lives; as many as...Cardiorenal Guidelines